Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Asthma in the Elderly: The Effect of Montelukast [Phase 4]
Phase 4 clinical trial evaluating the effect of montelukast in elderly patients with asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Smoking Cessation Intervention in Respiratory Inpatients [Phase 4]
Phase 4 clinical trial evaluating a smoking cessation intervention in respiratory inpatients has completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-04Clinical Trial Update: Pilot Study of RNS60 in Allergen-induced Bronchoconstriction [Phase 2]
The Phase 2 pilot trial of RNS60 for allergen-induced bronchoconstriction in asthma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients
Clinical trial update comparing omalizumab to non-omalizumab treatment in asthma patients. The status of the trial is listed as UNKNOWN.
-
FDA approval · 2016-09-30FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) from GlaxoSmithKline LLC, indicating an approved change t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use [NA]
The study completion update describes a pragmatic, clinic-focused trial of MedlinePlus Health Prescriptions sponsored by the University of M…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma [Phase 2]
Phase 2 results from a safety and efficacy study of inhaled R940343 in patients with mild to moderate asthma have been completed and results…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy [Phase 4]
A Phase 4 compassionate-access protocol evaluated the safety of Xolair (omalizumab) in patients aged 6 years and older with severe allergic …
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Asthma Surveillance and Education in Preschool Settings
The NHLBI-sponsored trial evaluating asthma surveillance and education in preschool settings has completed.
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Pathophysiologic Changes in the Respiratory System After Fire Smoke Inhalation [NA]
A completed clinical trial from Oslo University Hospital investigates pathophysiologic changes in the respiratory system following fire smok…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: MISSION Severe Asthma Modern Innovative Solutions to Improve Outcomes in Severe Asthma.
The document reports that the MISSION trial for severe asthma has completed, sponsored by Portsmouth Hospitals NHS Trust.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness
The AIR2 extension study for bronchial thermoplasty in asthma has completed and reported results assessing durability of effectiveness beyon…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Determine the Relationship Between Circadian Rhythms and Nocturnal Asthma
A completed Northwestern University-led clinical trial investigated the relationship between circadian rhythms and nocturnal asthma.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children [Phase 3]
A Phase 3 clinical trial evaluating inhaled albuterol sulfate for acute wheezing due to obstructive airway disease in children has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise [Phase 4]
Phase 4 study completed evaluating asthma control in pediatric and adolescent patients whose asthma worsens with physical activity. The spon…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Patients With Asthma [NA]
This document reports a completed clinical trial evaluating the effects of manual therapy and respiratory muscle training on maximal inspira…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Healthy Eating Better Breathing: A Feeding Study in Patients With Asthma [NA]
This clinical trial update reports the completion of a feeding study evaluating whether healthy eating improves breathing in patients with a…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Monitoring Adherence Using Mobile Technology
A clinical trial evaluating the use of mobile technology to monitor adherence in asthma patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Advair Pediatric Once-Daily [Phase 3]
This entry notes the completion of a Phase 3 trial evaluating Advair pediatric once-daily for asthma. The snippet does not provide trial res…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Aerosol Deposition in Asthmatic Obese Women Using Heliox [Phase 2]
A Phase 2 clinical trial evaluating aerosol deposition using heliox in women who are obese with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma. [Phase 2]
This Phase 2 clinical trial update reports on the evaluation of GW685698X given once daily (100 mcg in the morning or evening) and 250 mcg o…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Investigation Of A New Medication (GW642444) In Asthmatic Patients [Phase 2]
Phase 2 trial of GW642444 in asthmatic patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. [Phase 4]
Phase 4 clinical trial update for asthma in children evaluating Seretide Diskus Inhaler (salmeterol xinafoate / fluticasone propionate) and …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. [Phase 4]
This Phase 4 trial compares a stable dose SERETIDE inhaler with an adjustable maintenance dose SYMBICORT inhaler over one year in asthma.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies. [Phase 4]
A Phase 4 study evaluating airway physiology in adults involving Seretide Diskus and Flixotide inhalers; the asthma trial has completed.